Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -6.53% is 70% above its 5-year average of -21.69%, near the high end of its 5-year range (-30.75%–-6.53%).
As of the fiscal period ended Tuesday, June 30, 2026. 56.20% above its 12-month average of -14.90%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -6.53%.
RETURN ON INVESTED CAPITAL (ROIC)
-6.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-14.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-21.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-21.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+56.20%
CURRENT VS 3Y AVG
+69.53%
CURRENT VS 5Y AVG
+69.91%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 766 covered companies
CURRENT VS SECTOR MEDIAN
+81.05%
vs the sector median at left
Establishment Labs Holdings Inc.
Market Cap
$1.91B
Return on Invested Capital (ROIC)
-6.53%
TTM Avg
-14.90%
3Y Avg
-21.42%
5Y Avg
-21.69%
Market Cap
$1.90B
Return on Invested Capital (ROIC)
-44.21%
TTM Avg
-32.05%
3Y Avg
-35.56%
5Y Avg
-35.59%
Market Cap
$1.89B
Return on Invested Capital (ROIC)
-51.06%
TTM Avg
-99.01%
3Y Avg
-126.31%
5Y Avg
-97.79%
Market Cap
$1.89B
Return on Invested Capital (ROIC)
1.72%
TTM Avg
-1.08%
3Y Avg
-2.19%
5Y Avg
-2.71%
Market Cap
$1.95B
Return on Invested Capital (ROIC)
-4.68%
TTM Avg
-2.93%
3Y Avg
-9.02%
5Y Avg
-10.48%
Market Cap
$1.97B
Return on Invested Capital (ROIC)
-57.17%
TTM Avg
-63.49%
3Y Avg
-47.92%
5Y Avg
-137.67%
Market Cap
$1.85B
Return on Invested Capital (ROIC)
4.13%
TTM Avg
4.21%
3Y Avg
5.71%
5Y Avg
5.17%
Market Cap
$1.98B
Return on Invested Capital (ROIC)
6.33%
TTM Avg
5.44%
3Y Avg
-1.33%
5Y Avg
-7.01%
Market Cap
$1.85B
Return on Invested Capital (ROIC)
-1.33%
TTM Avg
-1.10%
3Y Avg
-1.49%
5Y Avg
-1.29%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Establishment Labs Holdings Inc. (ESTA) | $1.91B | -6.53% | -14.90% | -21.42% | -21.69% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | -44.21% | -32.05% | -35.56% | -35.59% |
| Immunome, Inc. (IMNM)vs › | $1.89B | -51.06% | -99.01% | -126.31% | -97.79% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 1.72% | -1.08% | -2.19% | -2.71% |
| AxoGen, Inc. (AXGN)vs › | $1.95B | -4.68% | -2.93% | -9.02% | -10.48% |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.97B | -57.17% | -63.49% | -47.92% | -137.67% |
| Astrana Health, Inc. (ASTH)vs › | $1.85B | 4.13% | 4.21% | 5.71% | 5.17% |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.98B | 6.33% | 5.44% | -1.33% | -7.01% |
| Azenta, Inc. (AZTA)vs › | $1.85B | -1.33% | -1.10% | -1.49% | -1.29% |
| Novavax, Inc. (NVAX)vs › | $1.84B | -36.37% | 8.48% | -213.38% | -299.96% |
ROIC
-6.5%
ROE
-180.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -6.53% |
| 2026-03-31 | -10.24% |
| 2025-12-31 | -13.57% |
| 2025-09-30 | -19.41% |
| 2025-06-30 | -24.76% |
| 2025-03-31 | -21.98% |
| 2024-12-31 | -17.95% |
| 2024-09-30 | -23.01% |
| 2024-06-30 | -25.22% |
| 2024-03-31 | -25.88% |
| 2023-12-31 | -30.75% |
| 2023-09-30 | -25.46% |
| 2023-06-30 | -18.82% |
| 2023-03-31 | -25.16% |
| 2022-12-31 | -23.04% |
| 2022-09-30 | -23.10% |
| 2022-06-30 | -20.83% |
| 2022-03-31 | -27.24% |
| 2021-12-31 | -23.36% |
| 2021-09-30 | -20.18% |
| 2021-06-30 | -13.89% |
| 2021-03-31 | -17.49% |
| 2020-12-31 | -21.39% |
| 2020-09-30 | -18.06% |
| 2020-06-30 | -22.37% |
| 2020-03-31 | -20.73% |
| 2019-12-31 | -33.17% |
| 2019-09-30 | -35.91% |
| 2019-06-30 | -38.89% |
| 2019-03-31 | -31.79% |
| 2018-12-31 | -23.83% |
| 2018-09-30 | -18.60% |
| 2018-06-30 | -39.82% |
| 2018-03-31 | -43.89% |
| 2017-12-31 | -84.15% |
